While this happened, Cantor Fitzgerald initiated its Jaguar Health Inc [JAGX] rating to an Overweight in a research note published on July 07, 2021; the price target was $5. A number of analysts have revised their coverage, including Rodman & Renshaw’s analysts, who began to cover the stock in mid July with a ‘”a Buy”‘ rating.
Price Performance Review of JAGX
On Friday, Jaguar Health Inc [NASDAQ:JAGX] saw its stock jump 35.36% to $10.91. Over the last five days, the stock has gained 98.00%. Jaguar Health Inc shares have fallen nearly -56.79% since the year began. Nevertheless, the stocks have fallen -95.67% over the past one year. While a 52-week high of $540.00 was reached on 01/06/25, a 52-week low of $4.02 was recorded on 04/07/25. SMA at 50 days reached $10.48, while 200 days put it at $26.24.
Levels Of Support And Resistance For JAGX Stock
The 24-hour chart illustrates a support level at 7.59, which if violated will result in even more drops to 4.28. On the upside, there is a resistance level at 14.85. A further resistance level may holdings at 18.80. The Relative Strength Index (RSI) on the 14-day chart is 70.55, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.54, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 39.88%. Stochastics %K at 74.42% indicates the stock is a holding.
How much short interest is there in Jaguar Health Inc?
A steep rise in short interest was recorded in Jaguar Health Inc stocks on 2025-04-15, growing by 17597.0 shares to a total of 53245.0 shares. Yahoo Finance data shows the prior-month short interest on 2025-03-14 was 35648.0 shares. There was a rise of 33.05%, which implies that there is a positive sentiment for the stock.
